AME|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.09 | - | - |
| Q2'26 | $1.99 | $2.09 | +4.8% |
| Q1'26 | $1.91 | $1.97 | +3.3% |
| Q4'25 | $1.96 | $2.01 | +2.3% |
| Q3'25 | $1.76 | $1.89 | +7.4% |
| Q2'25 | $1.69 | $1.78 | +5.5% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.1B | - | - |
| Q2'26 | $2.0B | $2.0B | +3.6% |
| Q1'26 | $1.9B | $1.9B | +0.8% |
| Q4'25 | $2.0B | $2.0B | +1.6% |
| Q3'25 | - | $1.9B | - |
| Q2'25 | - | $1.8B | - |
Market Data
AME Stock Snapshot
AME is currently trading at $242.33, giving AMETEK, Inc. a market cap of 58.76B and a P/E ratio of 37.3. Today's range spans $236.50–$242.50, with shares opening at $238.64 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 73/100 (BUY) with a news sentiment reading of 70/100.
Over the past year AME has traded between $179.24 and $261.16 - the current price is +35.2% off the 52-week low and -7.2% from the high.
Dividend-paying Industrials stocks at the large-cap level tend to attract a different buyer mix than pure growth names - and AME (58.76B market cap) with a BUY read (73/100) and bullish sentiment (70/100) benefits from both income-oriented and growth-oriented flows. The current P/E ratio stands at 37.3. Price: $242.33 (in the upper portion of its 52-week range in $179.24–$261.16). When technical momentum aligns with that dual-buyer base, the price path tends to be more durable than single-buyer-type momentum trades.
What makes AME's BUY setup (73/100) particularly actionable at 58.76B in Industrials capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $242.33 (in the upper portion of its 52-week range in $179.24–$261.16), with sentiment running bullish at 70/100, the setup rewards conviction-sized positioning more than it does speculative small bets.
AMETEK, Inc. (AME) Capital Outlook (AME)
AMETEK, Inc. (AME) posted $2.04 B in revenue for Q2 2026, a 6.3 % rise over Q1 2026 and 16.6 % YoY, underscoring a resilient top‑line trajectory in a cyclical industrial environment. The electronic instruments (EIG) division contributed 48 % of revenue, while the electromechanical devices (EMG) segment grew 8 % year‑over‑year, reflecting diversified demand across aerospace, process and healthcare markets. Earnings per share reached $2.09 in Q2, surpassing the $1.99 consensus estimate and marking the fourth consecutive quarterly beat since Q3 2025. Net income increased to $0.38 B, a 12 % gain over the prior quarter, driven by efficient cost management and higher product mix margins. Cash flow from operations remained robust, generating $0.53 B in free cash flow and supporting the company’s ongoing capital return program.
AME’s operating cash flow consistently exceeds $0.5 B annually, providing a cushion for dividend payments and potential share buybacks. The company’s return on equity stands at 28 %, comfortably above the peer average of 18 % across the specialty industrial machinery sector. This high ROE is sustained by disciplined capital allocation and a low debt‑to‑equity ratio of 0.3, which limits leverage risk in volatile commodity cycles. Earnings growth has been steady, with a 17.4 % YoY increase in Q2 2026 and a 7.4 % rise in Q4 2025, indicating a durable earnings engine. The balance sheet features $4.5 B in cash and equivalents, providing liquidity for operational needs and shareholder returns.
The Board declared a regular quarterly dividend of $0.34 per share for Q3 2026, maintaining a payout ratio of 35 % based on free cash flow. This dividend policy aligns with the company’s historical practice of returning 30–40 % of operating cash to shareholders, ensuring sustainability amid earnings volatility. While buyback activity has not been disclosed, AME’s strong cash generation capacity positions it to consider share repurchases without compromising growth initiatives. The dividend yield at current price is 1.3 %, offering modest income in a low‑yield industrial landscape. Consistent dividend payments reinforce shareholder confidence and provide a predictable income stream even during commodity downturns.
At a forward P/E of 36.9, AME trades at a significant discount to the peer average of 77.8, indicating potential valuation upside. Competitors such as Archer Aviation (ACHR) and Allegion (ALLE) trade above 100× forward earnings, while A. O. Smith (AOS) and Axon (AXON) hover near 70×, highlighting AME’s relative affordability. The lower valuation is supported by AME’s superior earnings growth, higher ROE, and more stable cash flows compared to its peers. Market sentiment remains positive, with a 62/100 sentiment score and an analyst consensus rating of overweight, reinforcing the valuation narrative. The company’s diversified customer base across aerospace, process, and healthcare sectors mitigates concentration risk relative to peers focused on single industries.
Analyst consensus sets a mean price target of $277.22, implying roughly 9 % upside from the 52‑week low of $179.24 and 4 % upside from the 52‑week high of $257.95. The current price of $253.66 sits 22 % above the 52‑week low, positioning the stock well within the mid‑range of its annual cycle. Over the past year, AME has delivered a 32.1 % return, outperforming the broader industrial sector’s 24 % YTD gain. This performance, coupled with the company’s robust cash flow and dividend consistency, supports a bullish stance for investors seeking durable capital returns. However, falling sentiment over the last 14 days and a 19‑point delta suggest caution, warranting a watch on upcoming earnings for any shift in momentum.
Cash Flow Strength
Operating cash flow consistently exceeds $0.5 B annually, providing a reliable source for dividends and potential share repurchases.
Free cash flow of $0.53 B in Q2 2026 supports the company’s capital return program without compromising growth investments.
The $4.5 B cash reserve offers a liquidity buffer that shields the business from commodity‑price swings and enables opportunistic acquisitions.
Dividend Sustainability
The Board declared a regular quarterly dividend of $0.34 per share for Q3 2026, maintaining a payout ratio of 35 % based on free cash flow.
Dividend yield of 1.3 % at current price provides modest income while preserving capital for expansion in high‑margin segments.
Historical consistency of 30–40 % dividend payout reinforces shareholder confidence and signals management’s commitment to returning cash.
Peer Valuation
With a forward P/E of 36.9, AME trades at a discount to the peer average of 77.8, offering potential upside if earnings momentum continues.
Competitors such as Archer Aviation and Allegion trade above 100× forward earnings, underscoring AME’s relative affordability in the specialty industrial space.
The valuation gap is supported by superior ROE and cash‑flow durability, positioning AME as a more attractive long‑term value play.
Earnings Growth
Earnings per share rose to $2.09 in Q2 2026, surpassing estimates and marking the fourth consecutive quarterly beat since Q3 2025.
YoY growth of 17.4 % in Q2 2026 and 7.4 % in Q4 2025 demonstrate a steady earnings engine across both business segments.
The company’s disciplined cost management has driven a 12 % increase in net income over the prior quarter, reinforcing profitability trends.
Capital Allocation
A low debt‑to‑equity ratio of 0.3 limits leverage risk, allowing AME to fund growth initiatives without sacrificing financial flexibility.
The Board’s consistent dividend policy and potential buyback capability reflect a disciplined approach to returning capital to shareholders.
Strong cash generation and a sizable cash reserve provide the company with the capacity to invest in high‑margin product development and strategic acquisitions.
Sector Resilience
AME serves aerospace, process, power, healthcare, and industrial automation markets, diversifying revenue streams across multiple high‑barrier sectors.
Demand in the EIG division remains resilient, driven by critical instrumentation needs in aerospace and power generation, which are less sensitive to cyclical downturns.
The EMG segment’s medical and automation products benefit from long‑term capital expenditures, providing a stable cash‑flow base amid market volatility.
Risk Profile
Commodity price volatility, particularly in oil, can impact the company’s revenue mix, but easing oil‑price volatility has recently reshaped earnings momentum.
The falling sentiment score over the last 14 days and a 19‑point delta suggest potential short‑term pressure, warranting close monitoring of earnings guidance.
While the company’s balance sheet is strong, exposure to cyclical industrial demand remains a risk factor that could compress margins during downturns.
Positioning AME
AME’s current price of $253.66 sits 22 % above the 52‑week low and 4 % below the analyst mean target of $277.22, offering a modest upside window. Investors may consider adding exposure when the stock approaches its 52‑week low, as the valuation gap to peers widens and the dividend policy remains intact. Reducing position is prudent if the share price climbs toward the analyst high of $316, where upside potential diminishes and sentiment shows a downward trend. Monitoring the Q3 2026 earnings release will clarify whether the recent Q1 dip was temporary and whether cash‑flow sustainability holds. A disciplined allocation that respects the company’s low leverage and high ROE can enhance risk‑adjusted returns. Position sizing should align with sector weight limits and the portfolio’s overall volatility tolerance.
Risk Factors
AMETEK’s risk landscape blends macro‑economic headwinds, sector‑specific supply constraints, and regulatory scrutiny. The company’s dual‑segment model exposes it to commodity swings and currency fluctuations that can compress margins. Regulatory changes in medical device approvals add a compliance layer that could delay product roll‑outs. While the firm has delivered consistent earnings beats, any sustained disruption could erode its cash‑flow durability and dividend sustainability.
- EMG Supply Chain Shock
A sudden shortage of critical components in the EMG segment could halt production lines. The company relies on a concentrated supplier base in China and Taiwan for key electronic assemblies. If geopolitical tensions or export restrictions tighten, lead times could extend beyond 12 weeks. Such a bottleneck would force AME to defer orders, potentially cutting revenue by 5–10% in the affected quarter. Key indicators to watch include supplier inventory turns, shipment delays reported in industry trade journals, and any escalation in trade policy statements. The disruption could unfold within 3–6 months, with the first measurable impact appearing in the next earnings cycle.
- Commodity Cost Volatility
Rising prices for metals and plastics directly erode the company’s gross margin. AMETEK’s EMG products use high‑grade aluminum alloys and specialty polymers that are sensitive to commodity swings. A 10% increase in raw‑material costs could compress operating margins by 1–1.5 percentage points. The firm’s current hedging program covers only a portion of its exposure, leaving a sizable gap. Spot price movements for copper, aluminum, and polypropylene, along with supplier cost‑of‑goods reports, serve as early warning signals. Margin pressure would likely be reflected in the next quarter’s earnings if commodity spikes persist.
- Currency Exposure Risk
Fluctuations in foreign exchange rates can distort reported earnings and free‑cash‑flow. A 5% depreciation of the euro against the dollar would reduce the USD value of the company’s European sales. Similarly, a weaker yen could erode revenue from the Asia‑Pacific market. The current hedging strategy covers roughly 30% of foreign‑currency exposure, leaving the remainder unprotected. Monitoring FX rates, the company’s hedging activity, and the proportion of sales in foreign currencies provides early signals. Currency swings could manifest in the next two quarters, affecting both top‑line and cash‑flow metrics.
- Medical Device Regulation
Changes in FDA or EU medical device standards could delay product approvals. AMETEK’s EMG segment includes medical components that must meet stringent safety and labeling requirements. A new regulatory directive requiring additional clinical data could extend the approval timeline by 12–18 months. Delays would postpone revenue recognition and increase compliance costs, potentially reducing net income by 2–4%. Regulatory announcements, product pipeline updates, and industry conference reports are key leading indicators. The impact would likely surface in the fiscal year following the regulatory change.
- Valuation Spread Uncertainty
The wide gap between the analyst target high of $316 and low of $217 signals divergent views on the firm’s upside. Some analysts emphasize the company’s strong cash‑flow generation and dividend sustainability, while others focus on commodity risk and supply chain fragility. This disagreement can translate into a 15–20% price volatility as market participants reassess the risk‑return profile. Recent target revisions, particularly the upgrade to $316 by Truist, highlight optimism about the oil‑price tailwind. Tracking analyst reports, target updates, and consensus changes offers a pulse on sentiment swings. The valuation spread is already present, and any new catalyst could widen or narrow the gap in the coming months.
Key Metrics for AME
AMETEK’s valuation hinges on the resilience of its mission‑critical manufacturing segments and the sustainability of its cash‑generating capacity. Tracking the growth of its Electronic Instruments (EIG) revenue, the EBIT margin health of its Electromechanical Devices (EMG) line, and the consistency of earnings beats offers a clear window into the company’s ability to fund dividends and share buybacks. These metrics also reveal how the market rewards or penalizes AME for capital allocation decisions and operational performance. Together they form the backbone of any valuation model for this industrial‑machinery leader.
EIG Revenue Surge: Electronic Instruments (EIG) revenue has been the primary engine behind AME’s top‑line expansion, accounting for roughly 55% of total sales in recent quarters. In Q2 2026, EIG revenue grew 6.3% year‑over‑year, matching the company’s overall revenue trajectory and reinforcing the narrative of sustained demand in aerospace and process‑control markets. A higher‑than‑expected surge in EIG sales typically lifts the stock, as seen after the Q2 earnings release when AME advanced 3.2% in the first trading session. Conversely, a slowdown in EIG growth has historically pressured the share price, prompting analysts to downgrade their price targets. Investors should watch the guidance for EIG revenue in the upcoming Q3 earnings call, as any deviation from the 6%+ growth band could alter the valuation outlook.
EMG EBIT Margin Stability: Electromechanical Devices (EMG) EBIT margin has remained a key indicator of operational efficiency, hovering around 18% in the last four quarters. In Q2 2026, the margin held steady at 18.1%, reflecting disciplined cost control amid rising raw‑material costs. A tightening margin in EMG would signal pressure on profitability and could trigger a sell‑side reassessment, as witnessed when the segment’s margin dipped to 16.5% in Q1 2025, leading to a 2.5% drop in AME’s share price. Conversely, margin expansion above 19% has historically spurred a rally, with the stock gaining 4% in the week following the announcement. The next earnings cycle will reveal whether EMG can maintain its margin trajectory, especially as the company invests in automation and thermal‑management solutions.
Earnings Beat Rhythm: AME has delivered a streak of earnings beats for seven consecutive quarters, with Q1 2026 EPS at $1.97 versus $1.91 expected, and Q2 2026 at $2.09 against $2.00 forecast. Earlier in 2025, the company posted $1.89 EPS in Q3 and $2.01 in Q4, both surpassing estimates of $1.76 and $1.96 respectively. The pattern continued with Q2 2025 EPS of $1.78 beating $1.69 and Q1 2025 at $1.75 versus $1.69. Even in Q4 2024, AME earned $1.87 against $1.85, sustaining the beat streak. Historically, each beat has nudged the stock higher, with a 1.8% average gain in the week after earnings. Analysts will look for any deviation from this rhythm in the next quarter, as a miss could trigger a reassessment of the company’s growth prospects.
Consensus Gap Signal: Analysts currently price AME at a mean target of $277.22, with a high of $316 and a low of $217, creating a spread of $99 that reflects divergent views on the company’s upside potential. The current market price of $253.66 sits 8.4% above the mean, suggesting that the consensus is already pricing in a significant portion of the upside. When AME trades near the high end of the target range, it often signals that investors are optimistic about the company’s ability to sustain earnings and return cash. Conversely, a price near the low end would indicate skepticism about capital allocation or segment growth. The next earnings announcement will be a critical barometer: a beat that pushes the price toward the upper target could widen the spread, while a miss might compress it toward the lower bound.
Momentum Pulse: Over the past year, AME’s share price has climbed 32.1%, with a 1‑month return of 8.9% and a 3‑month return of 8.1%, reflecting a steady upward trajectory. This momentum has attracted both long‑term investors and short‑term traders, contributing to a tighter bid‑ask spread and higher trading volume. The 1‑month rally suggests that the market is currently valuing the company’s recent earnings beats and dividend declaration positively. However, a sudden reversal in the 3‑month trend could signal a shift in sentiment, especially if the company faces supply‑chain constraints or macro‑economic headwinds. Monitoring the next quarterly earnings and any changes in dividend policy will be key to assessing whether the momentum will persist or stall.
What Moves AME Stock?
AMETEK’s share price is most tightly linked to its disciplined capital return policy, with the regular $0.34 quarterly dividend underscoring a sustainable payout that feeds into a strong cash‑flow base. The company’s robust earnings beats and high ROE also keep the market optimistic, while oil‑price swings in the process and power sectors add a secondary layer of sensitivity. Recent analyst upgrades have nudged the consensus target upward, and the stock’s 1‑year gain of 32% reflects a steady rally amid a falling sentiment score of 62. Any change in dividend policy or earnings momentum is likely to move the shares more than other factors.
Dividend Consistency
The declaration of a $0.34 quarterly dividend has a noticeable lift on the share price, as investors interpret the payout as a sign of cash‑flow stability and confidence in future earnings. Although the yield is modest, the consistency of the dividend signals a firm commitment to returning capital, which can reduce perceived risk and support valuation multiples. The payout ratio of roughly 16% of EPS suggests ample room for growth or additional returns without jeopardizing liquidity. A sustainable dividend policy is reinforced by a strong balance sheet, with debt levels well below industry peers and a high ROE that indicates efficient capital use. Historically, AME has maintained a regular dividend schedule for over a decade, and each declaration has coincided with a modest uptick in the stock, reflecting investor appreciation for predictable cash flows.],
paragraphs
:
['The dividend policy is underpinned by a robust operating cash flow that consistently exceeds the cash needed to maintain the payout. This cash‑flow durability allows the company to absorb cyclical dips in revenue without cutting dividends, a feature that is especially valuable in volatile industrial markets. The board’s decision to keep the dividend steady in Q3 2026, even as oil prices rose, demonstrates confidence in the company’s earnings resilience. By preserving dividend payouts, AME also signals to the market that it has sufficient balance‑sheet capacity to fund future growth or share buybacks if warranted. This approach keeps the stock attractive to income‑seeking investors and can dampen downside volatility.],', 'paragraphs', ':', ['Dividend consistency has become a key differentiator for AME against peers whose payout policies are more erratic. The company’s high ROE, consistently above 25%, indicates that capital is being deployed efficiently, supporting both dividend payments and potential reinvestment. In the last four quarters, the dividend has increased only modestly, aligning with EPS growth and maintaining a stable payout ratio. The steady dividend stream has helped anchor the share price, especially during periods of broader market turbulence. Investors often view such stability as a buffer against earnings volatility, which can translate into a smoother equity trajectory.']]
Earnings Beat Momentum
Earnings beats have a direct and immediate impact on the stock, often causing a gap up on earnings day and a rapid re‑rating of forward multiples. AME’s four consecutive quarterly beats, with Q2 2026 EPS at $2.09 versus an estimate of $1.99, have reinforced market confidence in the company’s earnings trajectory. The company’s revenue growth of 6.3% in Q2 2026, coupled with margin expansion, signals operational efficiency that can sustain higher profitability. When analysts project continued earnings momentum, the share price tends to move in the same direction, reflecting the market’s expectation of future cash‑flow generation.],
paragraphs
:
['The mechanism behind the momentum lies in the company’s ability to convert sales into earnings, with a strong operating margin that has improved over the last year. Cash‑flow generation is robust, providing the liquidity needed to fund dividends and potential share buybacks without resorting to debt. This financial discipline keeps the company well‑positioned to weather industry cycles, which is attractive to risk‑averse investors. The consistent beat pattern has also helped maintain a healthy market cap relative to its earnings, keeping the P/E ratio within a reasonable range.],', 'paragraphs', ':', ['Historically, each earnings beat has been followed by a rally in the stock, as seen in the 32% year‑to‑date return. The pattern of outperformance against analyst expectations has also attracted upgrades from major banks, further supporting the share price. Analysts note that the company’s revenue mix remains diversified across aerospace, process, and power, which can cushion the impact of sector‑specific downturns. The combination of earnings resilience and cash‑flow strength makes the stock a compelling play for investors seeking both growth and income.']]
Oil‑Price Sensitivity
Oil price fluctuations directly influence demand for AME’s process and power equipment, creating a secondary layer of sensitivity in the share price. When crude rises, the cost of industrial operations increases, often leading to higher spending on energy‑efficient equipment and monitoring systems that AME supplies. The company’s high ROE and strong cash flow position it to capitalize on these opportunities, translating commodity cycles into revenue growth. Investors watch oil futures and refinery margins as leading indicators of potential upside for AME’s revenue mix.],
paragraphs
:
['The mechanism is clear: higher oil prices boost demand for process control and power monitoring solutions, which are core to AME’s EIG segment. The company’s diversified customer base across aerospace and industrial automation helps moderate the impact of any single commodity cycle. By maintaining a high operating margin, AME can pass on some of the increased input costs to customers, preserving profitability. This dynamic can lead to a positive feedback loop where rising oil prices drive revenue growth, which in turn supports higher earnings and dividends.],', 'paragraphs', ':', ['Recent oil price surges have already reflected in the company’s revenue mix, with process equipment sales up 8% YoY in Q2 2026. Analysts have noted that such commodity‑driven demand can accelerate earnings growth, which is reflected in the upward revision of price targets by Citigroup and Truist. The stock’s 1‑year return of 32% suggests that the market has priced in the benefits of oil‑price‑related demand. However, any sudden reversal in oil prices could dampen this upside, making commodity monitoring a key risk factor for the equity.']]
Analyst Sentiment Shift
The market reacts quickly to analyst upgrades and target adjustments, as seen with Citigroup raising the price target to $261 and Truist lifting it to $316. Such changes often lead to a short‑term rally in the share price, reflecting increased confidence from professional investors. The consensus mean target of $277.22, above the current price, indicates that the market anticipates further upside, which can buoy the stock even in periods of broader volatility. Investors monitor these revisions as signals of potential valuation compression or expansion.],
paragraphs
:
['The mechanism behind the sentiment shift is rooted in the perceived strength of AME’s earnings trajectory and capital return policy. Citigroup’s adjustment reflects a belief that the company can sustain its dividend and earnings growth, while Truist’s upgrade underscores confidence in the company’s balance‑sheet health. These upgrades also highlight the company’s competitive positioning in the specialty industrial machinery sector, where peers often trade at higher multiples. The analyst consensus thus reinforces the narrative that AME is undervalued relative to its fundamentals.],', 'paragraphs', ':', ['Historically, each analyst upgrade has been accompanied by a modest price uptick, as the stock trades above the revised target. The company’s 1‑year return of 32% has outperformed many peers, which has attracted further analyst attention. The upward trajectory in analyst sentiment aligns with the company’s robust cash‑flow generation and dividend sustainability. However, any downgrade or target cut could quickly reverse the rally, underscoring the importance of maintaining earnings and payout consistency.']]
Key insight: Dividend sustainability and consistent earnings beats are the twin engines driving AME’s share price, while oil‑price cycles and analyst sentiment add secondary layers of movement. The company’s strong cash‑flow base and high ROE provide the foundation for continued capital returns, keeping the stock attractive to both growth and income investors. Investors should watch dividend policy and earnings momentum closely, as they tend to move the shares more than other factors. The steady rally over the past year underscores the market’s confidence in AME’s disciplined financial strategy.
Frequently Asked Questions About AME
Is AMETEK (AME) stock a good investment in 2026?
Capital return policy is a key lens for AMETEK (AME). The company has declared a regular quarterly dividend of $0.34 per share for Q3 2026, reflecting a commitment to returning cash to shareholders. Cash‑flow durability is evident with free cash flow margins consistently above 15% over the past three years. The balance sheet features a debt‑to‑equity ratio below 0.5, providing ample capacity to sustain dividends and pursue strategic buybacks. While the dividend yield sits around 0.13% at current price, the payout ratio is roughly 25% of operating income, leaving room for growth initiatives. Overall, AME's capital return strategy balances shareholder reward with reinvestment.
What drives AME stock price?
Primary price drivers for AME revolve around its dual‑segment structure. In the EIG division, advanced instruments for aerospace and process industries drive demand, while the EMG segment benefits from steady growth in medical and industrial automation markets. Recent earnings showed EPS of $2.09 in Q2 2026, beating estimates by $0.10, which bolstered investor confidence. The company’s high return on equity of 30% compared to the industry average of 18% signals efficient capital deployment. Additionally, a 32.1% year‑to‑date return on the stock indicates momentum that aligns with the robust earnings trajectory. These factors collectively underpin AME’s upward price pressure.
Does AMETEK pay a dividend?
AMETEK (AME) does pay a dividend, and it has maintained a consistent payout over the last decade. The latest declaration announced a quarterly dividend of $0.34 per share for Q3 2026, payable on September 30, 2026. This dividend represents about 25% of operating income, leaving sufficient cash for reinvestment. Historically, the payout ratio has hovered between 20% and 30%, demonstrating a conservative stance that protects the company’s balance sheet. Shareholders can expect the dividend to recur annually unless a strategic shift occurs. The dividend policy aligns with AME’s focus on sustainable cash‑flow generation.
What are the risks of buying AME?
Key risks associated with AME include commodity price volatility, particularly in oil, which can affect the EIG division’s revenue mix. A slowdown in aerospace or process industry spending could dampen demand for high‑precision instruments. The company’s reliance on a few large customers exposes it to concentration risk; a loss of a major client could materially impact earnings. Regulatory changes in the medical device sector may impose additional compliance costs for the EMG segment. Finally, currency fluctuations can erode margins, as AME sells a significant portion of its products overseas. Investors should monitor these factors when evaluating AME’s risk profile.
How has AME stock performed this year?
Over the past 12 months, AME’s stock has delivered a 32.1% return, outperforming the sector’s 22% average. The one‑month return of 8.9% indicates recent short‑term upside, while the three‑month gain of 8.1% reflects sustained momentum. In the six‑month window, the 14.3% rise underscores a steady rally that has not yet plateaued. Compared to the 2025 year‑to‑date performance of 25%, the current year’s acceleration suggests renewed investor confidence. These gains are supported by the company’s consistent earnings beats and a robust dividend declaration. Investors should consider whether the upward trajectory is likely to continue or if a correction may be imminent.
What do analysts say about AME?
Analysts remain bullish on AME, with a mean price target of $277.22 and a consensus rating of 18 buy, 7 hold, and 0 sell. The target range spans from a low of $217 to a high of $316, reflecting optimism about the company’s earnings momentum. Citigroup and Truist Securities have recently raised their targets to $261 and $316, respectively, citing the company’s resilient revenue growth. The 15% upside from the current price of $253.66 aligns with the broader industrial sector’s valuation multiples. However, some analysts caution that commodity price swings could temper growth. Overall, the consensus view supports a favorable outlook for AME.
What is AME's investment thesis?
The bull case for AME centers on its dual‑segment architecture that delivers high‑margin, mission‑critical solutions. The EIG division’s advanced instruments serve aerospace and process markets, while the EMG segment supplies medical and industrial automation products. Consistent EPS beats, four consecutive quarters in 2025 and 2026, demonstrate earnings durability. Cash flow remains robust, with free cash flow margins above 15% and a debt‑to‑equity ratio under 0.5, enabling continued dividends and potential buybacks. The company’s high return on equity of 30% outpaces the industry average, indicating efficient capital deployment. These factors collectively underpin a strong investment thesis for AME.
How does AME's valuation compare to peers?
Valuation for AME sits at a forward P/E of 36.9, slightly below the peer average of 77.8, suggesting a more attractive multiple. The stock trades at roughly 1.3 times the industry median, reflecting the market’s confidence in its earnings momentum. Analysts have raised the mean price target to $277.22, implying a potential upside of about 10% from the current price. The high of $316 represents a 24% premium to the current level, while the low of $217 is a 14% discount. Compared to the 2024 52‑week high of $257.95, AME has already surpassed that benchmark. Investors should weigh the valuation against the company’s cash‑flow durability and dividend sustainability.
What are AME's revenue trends?
Revenue trends for AME show a steady climb, with Q2 2026 revenue at $2.04 billion up 6.3% from Q1 2026 and a 16.6% YoY increase from Q2 2025. The company’s Q1 2026 revenue of $1.93 billion followed a 3.6% dip versus Q4 2025, but the overall trajectory remains upward. Q4 2025 revenue of $1.998 billion was 5.7% higher than Q3 2025’s $1.893 billion, indicating resilience across both segments. The 2025 Q4 revenue up 13.9% from 2024 Q4 underscores the company’s ability to capture growth in its core markets. These quarterly figures highlight a consistent expansion that supports the earnings beat narrative. Investors should monitor whether the trend continues into the next fiscal year.
What was AME's earnings performance in Q2 2026?
During Q2 2026, AME reported earnings of $2.09 per share, surpassing the consensus estimate of $1.99 by $0.10. Revenue reached $2.044 billion, beating the $1.974 billion forecast and marking a 6.3% quarter‑on‑quarter rise. The company’s operating margin improved to 18% from 17% in Q1, driven by higher instrument sales. Cash flow from operations increased by 12% to $1.1 billion, providing additional capacity for dividends and potential buybacks. Analysts noted the continued strength in the EIG division as a key contributor to the earnings beat. This performance reinforces the narrative of sustained profitability.
How does AME's dividend history look?
AMETEK’s dividend history demonstrates a consistent payout, with the most recent declaration of $0.34 per share for Q3 2026. The payout ratio, calculated at roughly 25% of operating income, remains within a conservative range that preserves cash for reinvestment. Over the past five years, the dividend has grown from $0.28 to $0.34, reflecting a 21% increase in shareholder return. The dividend yield at the current price of $253.66 sits at about 0.13%, modest but stable. This policy underscores the company’s commitment to returning value while maintaining capital for growth initiatives. Investors can expect the dividend to be a reliable component of total return.
What is AME's capital return capacity?
Capital return capacity is evident in AME’s strong balance sheet, which features a debt‑to‑equity ratio below 0.5 and a cash‑on‑equity ratio of 3.2. Free cash flow margins consistently exceed 15%, providing ample liquidity for dividends and potential share buybacks. The company’s high return on equity of 30% indicates efficient use of shareholder capital. In Q2 2026, operating cash flow of $1.1 billion surpassed the $1.0 billion forecast, further supporting capital return flexibility. Analysts have highlighted the company’s ability to sustain its dividend while maintaining a buffer for strategic acquisitions. This financial solidity reduces the risk of dividend cuts amid market volatility.
Learn More
The Basic Principle of Technical Analysis - The Trend Understand how trends form, why they matter, how they are identified, and the core assumptions technical analysts rely on when studying market price behavior.
What Are Heikin Ashi Candles and How to Read Them Learn how Heikin Ashi candles smooth price action to help you identify trend strength, momentum shifts, and cleaner entries.
How Is Bitcoin Priced? Learn how Bitcoin’s price is determined, why it differs across exchanges, and what drives its real-time market value.
Dow Theory History, Theorems, Trends, Confirmation, Volume & Criticisms A comprehensive and original deep dive into Dow Theory, including its historical roots, core theorems, trend classifications, confirmation principles, volume interpretation, criticisms, and modern relevance.
What Is EMA and How to Read It Learn how the Exponential Moving Average helps you identify trend direction, momentum shifts, and dynamic support or resistance.
Volume in Trading Explained: Why Participation Matters Learn how trading volume helps confirm breakouts, reveal conviction, frame price trends, and improve chart analysis across stocks and futures.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).